The application for our 2013 course is now available! See "How To Apply"
section. the right. For more information email Shaughnessy Dixson at firstname.lastname@example.org
Applicants are accepted on a competitive basis. Applications can be submitted until May 31, 2013 or until the course is full. Early application submission is encouraged, as space is limited. Acceptance notifications will be emailed on the first of the month in April, May, and June.
March 22, 2013 (Early Acceptance)
Applications received before 3/22/2013 - notification of application status by APRIL 1
Applications received after 4/1/2013 - notification by MAY 1
Applications received after 5/1/2013 - notification by JUNE 1
Two team members from one institution (comprehensive cancer center, community cancer center, hospitals with oncology programs) may apply:
One team member must be a nurse, physician, social worker or administrator (TIER 1).
The second team member may be anyone in Tier 1 or other healthcare professionals such as psychologists, spiritual care professionals, health educators, etc., who participate in the care of cancer patients (TIER 2).
In the application process teams will develop three Family Caregiver-related goals for institutional change. During the course teams can adjust and/or refine their goals. Post course, the teams will implement these goals at their home institution. A evaluation process will be used to measure team progress (See Expected Results).
Institutional support of the team is required and is indicated by a letter of support from one institution administrator.
As each team implements their goals at their home institution and build a framework for institutional change, there will be improvement in the quality of life and quality of care for Family Caregivers.
The achievement level of goal-driven change will be evaluated at 6, 12, and 18 months. Teams will provide goal updates and complete a brief follow-up survey, and phone interviews at 6, 12, and 18 months. Continuous access to supportive faculty will be available throughout the 18-month follow-up period.